Company Info

Number of Employees

18000

Revenue

$778.5

Visit Website

WuXi AppTec

CDMO, CRO, Pharma Intermediates

Tagline

Global Platform. One Vision

Overview

WuXi AppTec is a global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform providing a range of services across the full spectrum of drug development R&D. With operations in China and the United States, WuXi AppTec has enhanced its integrated offering from an initial focus on discovery chemistry to a full range of services and solutions that support customers from discovery through commercialization. Under the WuXi AppTec corporate umbrella sit several interdependent business units that together support the organization’s mission to better serve its customers with accelerated timelines, lower costs and increased efficiencies in drug and medical device R&D.

Company Services

Services/CapabilitiesCDMO

+ Biomanufacturing

cGMP Microbial Manufacturing
Vaccine Development & Manufacturing

+ Development Services

Analytical Development & Validation
Bioanalytical Services
Preformulation/Formulation
Process Development & Validation
Raw Material Testing
Scale Up/Tech Transfer
Stability Testing

+ Drug Product Manufacturing

Cytotoxic / High Potency Compounds (OEL < 1µg/m3)

+ Drug Substance Manufacturing

Advanced Intermediates

+ Packaging

Carton Packaging

Services/CapabilitiesCRO

Services/CapabilitiesPharma Intermediates

Contributors

Xin Zhang, Ph.D.

Company Info

WuXi AppTec

Tagline

Overview

Company Services

Services/CapabilitiesCDMO

Services/CapabilitiesCRO

Services/CapabilitiesPharma Intermediates

Contributors

Contributions

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility

Altasciences and WuXi AppTec Enter Into Collaboration for WIND Projects

WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development

The First WuXi Healthcare Forum Opens in Shanghai

WuXi AppTec Plans for Growth

WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan

WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance